Le Lézard
Classified in: Health

Thomas Valentine's New Book "Screams Overboard" Is A Piercing Account Of The Author's Moments Of Tragedy And His Struggle With Post-Traumatic Stress Disorder.


HENDERSON, Nev., June 25, 2018 /PRNewswire-PRWeb/ --Thomas Valentine, a hospital corpsman, third class, who served aboard the USS Saratoga and has participated in Operation Desert Shield, has completed his new book "Screams Overboard": a stirring novel recounting the author's death experience in a ferryboat accident that took the lives of his friends and shipmates.

Author Valentine proves the thought of time gradually wounding those who have met devastating moments, leaving emotional and psychological scars: "Several weeks at sea after the horrible accident, my mind and body remained fatigued, and I often broke out in hives. Being out to an open sea after all the tragic death we experienced made me more depressed. My appetite and job performance had dwindled quite considerably. I went from the always pleasant, smiling Mr. Popular Star Corpsman to a very angry, depressed, sluggish corpsman who didn't have any more compassion left inside."

Published by New York City-based Page Publishing, Thomas Valentine's riveting memoir also sheds light on understanding the psychology of post-traumatic stress disorder (PTSD) and how the afflicted scream a silent cry for help.

Readers who wish to experience this melodramatic work can purchase "Screams Overboard" at bookstores everywhere, or online at the Apple iTunes store, Amazon, Google Play, or Barnes and Noble.

For additional information or media inquiries, contact Page Publishing at 866-315-2708.

About Page Publishing:

Page Publishing is a traditional New York based full-service publishing house that handles all of the intricacies involved in publishing its authors' books, including distribution in the world's largest retail outlets and royalty generation. Page Publishing knows that authors need to be free to create - not bogged down with complicated business issues like eBook conversion, establishing wholesale accounts, insurance, shipping, taxes and the like. Its roster of authors can leave behind these tedious, complex and time-consuming issues, and focus on their passion: writing and creating. Learn more at http://www.pagepublishing.com.

 

SOURCE Page Publishing, Inc.


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: